Skip to main content

ADVERTISEMENT

outcomes research

Research in Review
10/12/2016
JCP Editors
Studies have assessed the feasibility of fast-track surgery in patients undergoing bariatric surgery. However, findings from a recent study published in Obesity Surgery showed that the degree of obesity influences...
Studies have assessed the feasibility of fast-track surgery in patients undergoing bariatric surgery. However, findings from a recent study published in Obesity Surgery showed that the degree of obesity influences...
...
10/12/2016
Journal of Clinical Pathways
Research in Review
10/11/2016
JCP Editors
Adjuvant endocrine therapy with tamoxifen or aromatase inhibitors may reduce the risk for contralateral breast cancer (CBC) in women with invasive breast cancer according to results from a study published in JAMA...
Adjuvant endocrine therapy with tamoxifen or aromatase inhibitors may reduce the risk for contralateral breast cancer (CBC) in women with invasive breast cancer according to results from a study published in JAMA...
...
10/11/2016
Journal of Clinical Pathways
Research in Review
09/06/2016
JCP Editors
Kidney-sparing surgery (KSS) and radical nephroureterecttomy (RNU) lead to similar survival for low-grade and noninvasive upper tract urothelial carcinoma (UTUC), according to a review published in European...
Kidney-sparing surgery (KSS) and radical nephroureterecttomy (RNU) lead to similar survival for low-grade and noninvasive upper tract urothelial carcinoma (UTUC), according to a review published in European...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
09/06/2016
JCP Editors
Patient-reported quality of life (QOL) may have prognostic value for long-term survival in disease-free survivors of surgically treated lung cancer who have completed active treatment, according to research published...
Patient-reported quality of life (QOL) may have prognostic value for long-term survival in disease-free survivors of surgically treated lung cancer who have completed active treatment, according to research published...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
05/13/2016
JCP Editors
Incidence of a common adverse event should not be considered a hindrance to the administration of everolimus for patients with cancer, according to a recent study. Everolimus is an oral mammalian target of rapamycin...
Incidence of a common adverse event should not be considered a hindrance to the administration of everolimus for patients with cancer, according to a recent study. Everolimus is an oral mammalian target of rapamycin...
...
05/13/2016
Journal of Clinical Pathways
03/10/2016
JCP Editors
Results from a study presented at the Society for Surgical Oncology Annual Cancer Symposium (March 2-5; Boston, MA) suggest that adhering to National Quality Forum (NQF) colon cancer quality metrics may not correlate...
Results from a study presented at the Society for Surgical Oncology Annual Cancer Symposium (March 2-5; Boston, MA) suggest that adhering to National Quality Forum (NQF) colon cancer quality metrics may not correlate...
...
03/10/2016
Journal of Clinical Pathways